Phone: 253-200-3166
Fax: 253-200-3167
Services
Comprehensive Oncologic and Diagnostic Imaging Services
We specialize in advanced diagnostic imaging and precision radiation therapy, offering cutting-edge solutions for cancer treatment and disease management. Our services include:
Diagnostic Imaging
Radiation Therapy
High-Dose Rate (HDR) Brachytherapy
Radioligand Therapy (Pluvicto, Lutathera, Xofigo)
Diagnostic Imaging
Utilizing state of the art imaging technology, including CT and PET to provide accurate and timely diagnoses.
CT (Computed Tomography) and PET (Positron Emission Tomography) are two advanced imaging techniques commonly used for cancer diagnosis, staging, and treatment planning. Each has unique strengths and is often used together as PET-CT for a more comprehensive evaluation.
Both CT and PET imaging play a crucial role in oncology, helping doctors diagnose cancer, plan therapies, and monitor disease progression effectively.
Radiation Therapy
Delivering targeted radiation treatments to destroy cancer cells while preserving healthy tissues. Our advanced techniques ensure optimal patient outcomes.
Radiation works by targeting cancerous tissues, disrupting their DNA, and preventing them from growing and dividing.
Cancer cells are far more sensitive to radiation than normal tissue cells. The ability for normal cells to resist and repair from radiation make this form of therapy perfect for cancer treatment.
HDR Brachytherapy
High-Dose Rate (HDR): A specialized form of internal radiation therapy that delivers high-intensity radiation directly to tumors, enhancing treatment effectiveness while minimizing exposure to surrounding tissues.
HDR brachytherapy is a powerful and efficient radiation treatment that enhances cancer control while reducing side effects. It has been utilized in cancer treatment for decades and the implementation has vastly improved over time.
Radioligand Therapy
Pluvicto, Lutathera, Xofigo
-
Pluvicto, also known as Lutetium-177 PSMA-617, is an innovative radioligand therapy designed for patients with advanced prostate cancer, combining targeted precision with therapeutic radiation to improve patient outcome.
-
Lutathera (Lutetium-177 DOTATATE) is a targeted radioligand therapy used for treating certain neuroendocrine tumors (NETs). Particularly for treating gastroenteropancreatic neuroendocrine tumors.
-
Xofigo (Radium-223 dichloride) is a targeted radiopharmaceutical therapy used to treat metastatic prostate cancer that has spread to the bones. It helps reduce pain and prolong survival in patients with bone metastases.
Request a Consultation
Location
2940 S Meridian #100, Puyallup, WA 98373
Reception: 253-200-3166
Billing Office: 253-200-3163
Fax: 253-200-3167